Used in research for targeting cancer cells, particularly in studies involving TRPM8 ion channel modulation. Shows potential in inducing cell death in certain tumor types, including prostate and pancreatic cancers. Investigated for its ability to selectively affect cancer cell viability with minimal impact on normal cells. Currently in preclinical development stages, serving as a lead compound for anticancer drug design.